Literature DB >> 19592602

Heart rate variability increases with reductions in cigarette smoke exposure after 3 days.

Sagar Munjal1, Tamara Koval, Raheema Muhammad, Yan Jin, Valentin Demmel, Hans J Roethig, Paul Mendes, Martin Unverdorben.   

Abstract

BACKGROUND: Smoking has been shown to influence the tone of the autonomic nervous system as reflected by heart rate variability (HRV). To date, no information is available as to whether 24-hour HRV might differentiate users of different tobacco products.
OBJECTIVE: To assess the differences in HRV derived from the 24-hour electrocardiogram (ECG) following the use of 2 tobacco products of potentially different exposures.
METHODS: Thirty adult Caucasian male smokers (mean age: 42.8 + 5.7 years) smoking 20 to 40 cigarettes/ day were randomized in a 3-way crossover study design to either smoke a conventional cigarette (CC, tar: 11 mg, Nic: 0.8 mg), to use the Electrically Heated Cigarette Smoking System (EHCSS: tar: 5 mg, Nic: 0.3 mg, according to the Federal Trade Commission [FTC]), or to stop smoking (NS) for 3 days each. The 24 hours ECGs were recorded during the last 24 hours of each exposure period.
RESULTS: A 24-hour ECG showed highest mean values for standard deviation of all normal-to-normal heart beat (NN) intervals (SDNN), standard deviation of all 5-minute averaged NN intervals in a 24-hour period (SDANN), mean of the standard deviations of the NN intervals calculated from all 5-minute segments in a 24-hour period (SDNNI), percentage (P) of all NN intervals that differ by 50 milliseconds of all NN (PNN50%), the square root of the mean of all squared differences between adjacent NN intervals in 24-hour period (RMSSD), and total number of all NN intervals divided by the height of the histogram of all NN intervals measured on a discrete scale with bins of 7 x 8125 ms (1/128 seconds; HRVTI) when participants stopped smoking followed by the use of the reduced exposure product and CC.
CONCLUSION: Heart rate variability tended to increase with reduced smoke exposure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592602     DOI: 10.1177/1074248409340340

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  8 in total

1.  Smoking's effects on respiratory sinus arrhythmia in adolescent smokers.

Authors:  Megan Conrad; Stephanie M Gorka; Jon Kassel
Journal:  Int J Psychophysiol       Date:  2015-05-07       Impact factor: 2.997

2.  Heart rate variability and heart rate recovery in lung cancer survivors eligible for long-term cure.

Authors:  Duc Ha; Atul Malhotra; Andrew L Ries; Wesley T O'Neal; Mark M Fuster
Journal:  Respir Physiol Neurobiol       Date:  2019-07-31       Impact factor: 1.931

Review 3.  Age related cardiovascular dysfunction and effects of physical activity.

Authors:  Fabio Galetta; Angelo Carpi; Nader Abraham; Emanuele Guidotti; Matteo A Russo; Marcello Camici; Alessandro Antonelli; Ferdinando Franzoni; Gino Santoro
Journal:  Front Biosci (Elite Ed)       Date:  2012-06-01

Review 4.  Interventions to reduce harm from continued tobacco use.

Authors:  Nicola Lindson-Hawley; Jamie Hartmann-Boyce; Thomas R Fanshawe; Rachna Begh; Amanda Farley; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2016-10-13

5.  Potential side effects of unhealthy lifestyle choices and health risks on basal and reactive heart rate variability in college drinkers.

Authors:  Tomoko Udo; Eun-Young Mun; Jennifer F Buckman; Evgeny G Vaschillo; Bronya Vaschillo; Marsha E Bates
Journal:  J Stud Alcohol Drugs       Date:  2013-09       Impact factor: 3.346

6.  Ivabradine improves heart rate variability in patients with nonischemic dilated cardiomyopathy.

Authors:  Ertugrul Kurtoglu; Sevket Balta; Yasin Karakus; Erdogan Yasar; Bilal Cuglan; Ozgur Kaplan; Gokhan Gozubuyuk
Journal:  Arq Bras Cardiol       Date:  2014-08-13       Impact factor: 2.000

7.  Favorable Changes in Biomarkers of Potential Harm to Reduce the Adverse Health Effects of Smoking in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 2).

Authors:  Christelle Haziza; Guillaume de La Bourdonnaye; Andrea Donelli; Dimitra Skiada; Valerie Poux; Rolf Weitkunat; Gizelle Baker; Patrick Picavet; Frank Lüdicke
Journal:  Nicotine Tob Res       Date:  2020-04-17       Impact factor: 4.244

8.  Effects of varenicline on sympatho-vagal balance and cue reactivity during smoking withdrawal: a randomised placebo-controlled trial.

Authors:  Helge Haarmann; Alexandra Gossler; Peter Herrmann; Slavtcho Bonev; Xuan Phuc Nguyen; Gerd Hasenfuß; Stefan Andreas; Tobias Raupach
Journal:  Tob Induc Dis       Date:  2016-08-08       Impact factor: 2.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.